Aisling Capital Partners IV, LP, 10% Owner at SUNESIS PHARMACEUTICALS INC (SNSS), bought 2,500,000 shares at $0.60 ($1.5M) on 2019-07-15, disclosed to the SEC on 2019-07-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.